Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03058380 · ClinicalTrials.gov registry record
Stated-Preferences in Knee Arthroplasty
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 348
- Enrollment target
NCT03058380: Completed study, sponsored by Duke University.
NCT03058380 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 348 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03058380 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 348 participants
- Enrollment target
Study Summary
The primary objectives of this study are to apply best-practice stated-preference methods to quantify patient preferences for benefit-risk tradeoffs associated with arthroplasty treatment options for end-stage osteoarthritis of the knee. Duke will develop and administer stated-preference surveys to adult patients (Ages 40-80) with knee pain to collect preference data, estimate the relative importance of treatment features and outcomes, and estimate maximum acceptable risks for given benefits and minimum acceptable benefits for given harms. This study proposal describes plans for the patient stated-preference survey.
Primary Outcome
Patient-stated preferences regarding treatment for knee pain based on questionnaires
Interventions
- OTHER Stated-Preferences Evaluation Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 348 participants |
| Start Date | 2017-08-17 |
| Est. Completion | 2018-06-01 |
What the finished NCT03058380 record still lists
NCT03058380 is an observational study that tracks outcomes without assigning an intervention. The registered 348 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Stated-Preferences Evaluation Instrument is the first listed.
NCT03058380 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03058380 about?
NCT03058380 is a clinical study titled "Stated-Preferences in Knee Arthroplasty". The primary objectives of this study are to apply best-practice stated-preference methods to quantify patient preferences for benefit-risk tradeoffs associated with arthroplasty treatment options for end-stage osteoarthritis of the knee. Duke will develop and administer stated-preference surveys to ...
What is the current status of trial NCT03058380?
This trial is currently completed. The enrollment target is 348 participants. The study started on 2017-08-17. Estimated completion is 2018-06-01.
What interventions are being tested in trial NCT03058380?
The interventions under investigation include: Stated-Preferences Evaluation Instrument (OTHER).
Who is sponsoring clinical trial NCT03058380?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041479 · 348 participants · Phase 3
Biomarker-guided rTMS for Treatment Resistant Depression
- NCT04530565 · 348 participants · Phase 3
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- NCT05428735 · 348 participants · NA
The DRAGON 2 Trial
- NCT05787379 · 348 participants · NA
Care for Veterans Post-COVID-19
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI